Format

Send to:

Choose Destination
See comment in PubMed Commons below
Ann Neurol. 2003;53 Suppl 3:S149-57; discussion S157-9.

Rationale for the use of dopamine agonists as neuroprotective agents in Parkinson's disease.

Author information

  • 1University Department of Clinical Neurosciences, Royal Free and University College Medical School, UCL, Queen Square, London, United Kingdom. schapira@rfc.ucl.ac.uk
PMID:
12666106
[PubMed - indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for John Wiley & Sons, Inc.
    Loading ...
    Write to the Help Desk